news

1、Tech-Enabled · Exclusive New Products Tailored to Southeast Asian Market Needs

On May 11, 2026, the Taiaitai Group’s new product launch event in Malaysia was held with great fanfare. The event featured the highly anticipated unveiling of a new line of small-molecule active peptides, custom-tailored specifically for the Southeast Asian market. This launch marks a significant milestone in the further implementation of Taiaitai’s globalization strategy, officially ushering in a new chapter in its deep-rooted expansion within the Southeast Asian health and wellness market.

2、Strategic Positioning: Leveraging Malaysia as a Hub to Radiate Across Southeast Asia

Tai Ai Tai Group made an appearance at this launch event, showcasing its cutting-edge biotechnology and core product portfolio. The newly released products focus on meeting consumer demands for “light wellness” and daily nutritional supplementation—needs that align closely with the consumption habits and health philosophies prevalent in Malaysia and the wider Southeast Asian region.

3、Backed by Strength · Driven by the Dual Engines of R&D and Production Capacity

During the press conference, Ms. Wu Xia, Chairperson of Tai’aitai Group, stated that Malaysia serves as the Group’s pivotal hub for its strategic expansion across Southeast Asia. Moving forward, the Group will leverage Malaysia as its central base to establish a regional operational platform that integrates R&D, production, marketing, and customer service. By continuously deepening collaborative development with local partners, the Group aims to facilitate the faster and more stable delivery of high-quality peptide-based health products to end-users.

Looking to the future · Deepening global cooperation

Leveraging 29 years of accumulated R&D expertise and over a hundred proprietary scientific achievements, Tai Ai Tai will continue to provide safe and trustworthy health solutions to the Southeast Asian market. This launch event marks not only the unveiling of new products but also a significant milestone in Tai Ai Tai’s global strategic expansion.

Moving forward, Tai Ai Tai Group will remain guided by technology and driven by market demand, continuously sharing the fruits of Chinese biotechnology, deepening regional cooperation in Southeast Asia, and serving consumers worldwide with its peptide-based products—thereby jointly fostering the high-quality development of the global health industry.